Co-Authors
                                
                                
                                    This is a "connection" page, showing publications co-authored by Maude Bouscambert-Duchamp and Florence Ader.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.293
         
        
        
     
 
    
        
        - 
            An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
            
            
                Score: 0.237
             
- 
            Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020. Clin Infect Dis. 2020 07 28; 71(15):825-832.
            
            
                Score: 0.056